Literature DB >> 7164948

Pharmacological properties of PAF-acether in the guinea-pig: platelet-dependent and independent reactions.

J Lefort, F Wal, M Chignard, M C Medeiros, B B Vargaftig.   

Abstract

The in vivo effects of PAF-acether in the guniea-pig are reviewed, particularly with respect to bronchoconstriction and to platelets, the former being suppressed when the latter are depleted. Bronchoconstriction by PAF-acether is not inhibited by aspirin, and when the latter was associated to mepyramine and to methysergide, bronchoconstriction was blocked, whereas thrombocytopenia persisted. Our results indicated that platelets collected from aspirin--mepyramine--methysergide-treated animals are less reactive for PAF-acether than control platelets, with respect to secretion of ATP, but aggregated fully. Secretion and aggregation are thus dissociable, the former being involved with bronchoconstriction. Results obtained with sulphinpyrazone and with reserpine are also discussed, and lead to the concept that platelet may release a presently unknown mediator when stimulated with PAF-acether.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7164948     DOI: 10.1007/bf01965092

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  14 in total

1.  Release of vasoactive substances from guinea-pig lungs by slow-reacting substance c and arachidonic acid. Its blockade by nonsteroid anti-inflammatory agents.

Authors:  B B Vargaftig; N Dao
Journal:  Pharmacology       Date:  1971       Impact factor: 2.547

2.  Platelet-activating factor induces a platelet-dependent bronchoconstriction unrelated to the formation of prostaglandin derivatives.

Authors:  B B Vargaftig; J Lefort; M Chignard; J Benveniste
Journal:  Eur J Pharmacol       Date:  1980-07-25       Impact factor: 4.432

Review 3.  Background and present status of research on platelet-activating factor (PAF-acether).

Authors:  B B Vargaftig; M Chignard; J Benveniste; J Lefort; F Wal
Journal:  Ann N Y Acad Sci       Date:  1981       Impact factor: 5.691

4.  Potent platelet stimulating activity of enantiomers of acetyl glyceryl ether phosphorylcholine and its methoxy analogues.

Authors:  D J Hanahan; P G Munder; K Satouchi; L McManus; R N Pinckard
Journal:  Biochem Biophys Res Commun       Date:  1981-03-16       Impact factor: 3.575

5.  Non-steroidal anti-inflammatory drugs if combined with anti-histamine and anti-serotonin agents interfere with the bronchial and platelet effects of "platelet-activating factor" (PAF-acether).

Authors:  B B Vargaftig; J Lefort; F Wal; M Chignard; M C Medeiros
Journal:  Eur J Pharmacol       Date:  1982-08-27       Impact factor: 4.432

6.  Purification and preliminary structure of a potent platelet aggregating glycoprotein isolated from the venom of Crotalus durissus cascavella.

Authors:  G Marlas
Journal:  Toxicon       Date:  1982       Impact factor: 3.033

7.  Differential effects of platelet depletion on the physiologic alterations of IgE anaphylaxis and acetyl glyceryl ether phosphorylcholine infusion in the rabbit.

Authors:  M Halonen; J D Palmer; I C Lohman; L M McManus; R N Pinckard
Journal:  Am Rev Respir Dis       Date:  1981-10

8.  Inhibition by sulphinpyrazone of the platelet-dependent bronchoconstriction due to platelet-activating factor (PAF-acether) in the guinea pig.

Authors:  M Chignard; F Wal; J Lefort; B B Vargaftig
Journal:  Eur J Pharmacol       Date:  1982-02-19       Impact factor: 4.432

9.  Enhancement by prostacyclin of the contractility of the guinea-pig airways smooth muscle.

Authors:  B B Vargaftig; J Lefort
Journal:  Eur J Pharmacol       Date:  1981-09-11       Impact factor: 4.432

10.  Mechanisms of bronchoconstriction and of thrombocytopenia induced by collagen in the guinea pig.

Authors:  B B Vargaftig; J Lefort; D Joseph; F Fouque
Journal:  Eur J Pharmacol       Date:  1979-10-01       Impact factor: 4.432

View more
  1 in total

1.  Platelet-activating factor (PAF) inhibitory profile of KO-286011 on blood platelets in vitro and in vivo.

Authors:  G Ostermann; B Hofmann; H P Kertscher; U Till
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-12       Impact factor: 3.000

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.